Inactivated Polio and Rabies Vaccines Market, by Vaccine (Inactivated Polio Vaccine and Inactivated Rabies Vaccine), by Method of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, and Others), by Age Group (Ped

Inactivated Polio and Rabies Vaccines Market, by Vaccine (Inactivated Polio Vaccine and Inactivated Rabies Vaccine), by Method of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, and Others), by Age Group (Pediatrics and Adults), by Distribution Channel (Government, and Private), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The incidences of polio globally is decreasing over the time due to government of the countries for creating awareness about the immunization against polio and rabies, among the population and increasing immunization camps. For instance, according to the World Health Organization (WHO), 2019, North America, Europe, and some Latin America are conducting polio immunization drives and creating awareness among the population, hence this has contributed to the eradication of polio from the regions.
The incidences of rabies have been controlled in high income countries while in low income countries the government is trying to increase the immunization in stray dogs as well as providing funding to the manufacturers to manufacture anti-rabies vaccines, in order to overcome the shortage of vaccines. For instance, several people of Asia Pacific and the African regions are reported to die due to rabies, therefore, government in these regions are conducting immunization drives, in which number of stray dogs are immunized against rabies.
Market Dynamics
Polio vaccines are of two types such as oral polio vaccine (OPV) and inactivated polio vaccine (IPV). OPV consist of live and weakened polio virus, which are more active than the IPV. The only disadvantage of OPV is the release of the live virus through the waste of the humans, which can spread to the non-immunized humans. Hence, government is taking an initiative of eliminating usage of OPV and increase the use of IPV gradually. Moreover, developed countries such as the U.S. have already stopped recommending oral polio vaccine since 2000. Many research and development is being carried out for the production of new IPV vaccine, which exhibits enhanced immune response against the disease as compared to the currently available IPV.
Manufacturers are indulged in the research and development of more efficient inactivated polio vaccine by addition of adjuvant to the vaccine. For instance, Fractional - dose Inactivated Polio Vaccine (fIPV) with adjuvant for increased stimulation of the immune response as compared to IPV alone. Moreover, according to the clinical trials that are conducted by the University of Vermont (sponsor) (Start date – 2019, estimated completion date – 2020, currently the trial is in phase I), fIPV along with the adjuvant, dmLT, is being tested on healthy human population in order to check the immune response in the presence and absence of the adjuvant.
Moreover, Sanofi Pasteur SA offers, IPOL, an IPV, which is prepared with a combination of three types of poliovirus such as Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett), which provides immunity against the three types of polio viruses, to the children (as young as 6 weeks of age) and in adults.
Government from different regions are taking initiative for the prevention of the spread of rabies in humans by immunizing animals. For instance, in 2019, Texas completed 25 years of dropping packets of rabies vaccine over wild-life areas and prevent the spread of the deadly virus in humans. Moreover, according to the Texas Department of State Health Services’ (DSHS) Oral Rabies Vaccination Program (ORVP) successfully distributed around 1 million vaccine doses on January 22, 2019. The program was initiated in 1995. Usually, rabies spread to humans through saliva of infected animals especially, dogs, bats and raccoon.
Key features of the study:
This report provides in-depth analysis of the global inactivated polio and rabies vaccines market and provides market size (US$ XX Million) and Cumulative Annual Growth Rate (CAGR (XX %)) for the forecast period (2022-2028), considering 2021 as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global inactivated polio and rabies vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc., Bilthoven Biologicals, Merck & Co., Inc., and Pfizer Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, end user upgrades, market expansion, and marketing tactics
The global inactivated polio and rabies vaccines market report caters to various stakeholders in this industry, including investors, device/system manufacturers, distributors and suppliers for anesthesia and respiratory devices, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the inactivated polio and rabies vaccines market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation
Global Inactivated Polio and Rabies Vaccine Market, By Vaccine:
Inactivated Polio Vaccines
Inactivated Rabies Vaccines
Global Inactivated Polio and Rabies Vaccine Market, By Method of Inactivation:
Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Others
Global Inactivated Polio and Rabies Vaccine Market, By Age Group:
Pediatrics
Adults
Global Inactivated Polio and Rabies Vaccine Market, By Distribution Channel:
Government
Private
Global Inactivated Polio and Rabies Vaccine Market, By Region:
North America
By Vaccine Type:
Inactivated Polio Vaccines
Inactivated Rabies Vaccines
By Method of Inactivation:
Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Others
By Age Group:
Pediatrics
Adults
By Distribution Channel:
Government
Private
By Country:
U.S.
Canada
Latin America
By Vaccine Type:
Inactivated Polio Vaccines
Inactivated Rabies Vaccines
By Method of Inactivation:
Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Others
By Age Group:
Pediatrics
Adults
By Distribution Channel:
Government
Private
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Vaccine Type:
Inactivated Polio Vaccines
Inactivated Rabies Vaccines
By Method of Inactivation:
Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Others
By Age Group:
Pediatrics
Adults
By Distribution Channel:
Government
Private
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Vaccine Type:
Inactivated Polio Vaccines
Inactivated Rabies Vaccines
By Method of Inactivation:
Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Others
By Age Group:
Pediatrics
Adults
By Distribution Channel:
Government
Private
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Vaccine Type:
Inactivated Polio Vaccines
Inactivated Rabies Vaccines
By Method of Inactivation:
Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Others
By Age Group:
Pediatrics
Adults
By Distribution Channel:
Government
Private
By Country:
GCC
Israel
Rest of Middle East
Africa
By Vaccine Type:
Inactivated Polio Vaccines
Inactivated Rabies Vaccines
By Method of Inactivation:
Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Others
By Age Group:
Pediatrics
Adults
By Distribution Channel:
Government
Private
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Bharat Biotech
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
BIO-MED
Serum Institute of India Pvt. Ltd.
Kedrion Biopharma Inc.
GlaxoSmithKline plc.
Bilthoven Biologicals
Merck & Co., Inc.
Pfizer Inc.